Ueyama Y - Search Results

1

The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer.

Inoue Y, Tomisawa M, Yamazaki H, Abe Y, Suemizu H, Tsukamoto H, Tomii Y, Kawamura M, Kijima H, Hatanaka H, Ueyama Y, Nakamura M, Kobayashi K. Inoue Y, et al. Among authors: ueyama y. Int J Oncol. 2003 Nov;23(5):1333-9. Int J Oncol. 2003. PMID: 14532974

2

Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.

Nagata J, Kijima H, Hatanaka H, Asai S, Miyachi H, Abe Y, Yamazaki H, Nakamura M, Watanabe N, Mine T, Kondo T, Scanlon KJ, Ueyama Y. Nagata J, et al. Among authors: ueyama y. Int J Oncol. 2002 Nov;21(5):1021-6. Int J Oncol. 2002. PMID: 12370750

3

Reversal of drug resistance mediated by hammerhead ribozyme against multidrug resistance-associated protein 1 in a human glioma cell line.

Osada H, Tokunaga T, Abe Y, Asai S, Miyachi H, Hatanaka H, Tsugu A, Kijima H, Yamazaki H, Shima K, Ueyama Y, Osamura Y, Nakamura M. Osada H, et al. Among authors: ueyama y. Int J Oncol. 2003 Apr;22(4):823-7. Int J Oncol. 2003. PMID: 12632074

4

Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.

Kijima H, Yamazaki H, Nakamura M, Scanlon KJ, Osamura RY, Ueyama Y. Kijima H, et al. Among authors: ueyama y. Int J Oncol. 2004 Mar;24(3):559-64. Int J Oncol. 2004. PMID: 14767540

5

The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.

Fujimori S, Abe Y, Nishi M, Hamamoto A, Inoue Y, Ohnishi Y, Nishime C, Matsumoto H, Yamazaki H, Kijima H, Ueyama Y, Inoue H, Nakamura M. Fujimori S, et al. Among authors: ueyama y. Int J Oncol. 2004 Aug;25(2):413-8. Int J Oncol. 2004. PMID: 15254739

6

The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.

Nishi M, Abe Y, Fujimori S, Hamamoto A, Inoue Y, Miyazaki N, Oida Y, Ikoma N, Ohnishi Y, Yamazaki H, Ueyama Y, Nakamura M. Nishi M, et al. Among authors: ueyama y. Oncol Rep. 2005 Aug;14(2):421-4. Oncol Rep. 2005. PMID: 16012725

7

Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.

Nakagawa T, Inoue Y, Kodama H, Yamazaki H, Kawai K, Suemizu H, Masuda R, Iwazaki M, Yamada S, Ueyama Y, Inoue H, Nakamura M. Nakagawa T, et al. Among authors: ueyama y. Oncol Rep. 2008 Aug;20(2):265-70. Oncol Rep. 2008. PMID: 18636185

8

Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells.

Tomii Y, Kamochi J, Yamazaki H, Sawa N, Tokunaga T, Ohnishi Y, Kijima H, Ueyama Y, Tamaoki N, Nakamura M. Tomii Y, et al. Among authors: ueyama y. Int J Oncol. 2002 Feb;20(2):339-42. Int J Oncol. 2002. PMID: 11788898

9

Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma.

Uwatoko N, Tokunaga T, Hatanaka H, Osada H, Kawakami T, Yamazaki H, Abe Y, Kijima H, Ueyama Y, Nakamura M. Uwatoko N, et al. Among authors: ueyama y. Int J Oncol. 2002 Apr;20(4):729-33. Int J Oncol. 2002. PMID: 11894117

10

Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line.

Kamochi J, Tokunaga T, Morino F, Nagata J, Tomii Y, Abe Y, Hatanaka H, Kijima H, Yamazaki H, Watanabe N, Matsuzaki S, Ueyama Y, Nakamura M. Kamochi J, et al. Among authors: ueyama y. Int J Oncol. 2002 Jul;21(1):81-4. Int J Oncol. 2002. PMID: 12063553

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters